Cargando…
Development of a Whole Blood Paper-Based Device for Phenylalanine Detection in the Context of PKU Therapy Monitoring
Laboratory-based testing does not allow for the sufficiently rapid return of data to enable optimal therapeutic monitoring of patients with metabolic diseases such as phenylketonuria (PKU). The typical turn-around time of several days for current laboratory-based testing is too slow to be practicall...
Autores principales: | Robinson, Robert, Wong, Liam, Monnat, Raymond J., Fu, Elain |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190008/ https://www.ncbi.nlm.nih.gov/pubmed/30407401 http://dx.doi.org/10.3390/mi7020028 |
Ejemplares similares
-
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
por: Daly, A., et al.
Publicado: (2019) -
Creatine energy substrate increases bone density in the Pah(enu2) classical PKU mouse in the context of phenylalanine restriction
por: Dobrowolski, Steven F., et al.
Publicado: (2023) -
PKU mutation p.G46S prevents the stereospecific binding of l‐phenylalanine to the dimer of human phenylalanine hydroxylase regulatory domain
por: Leandro, João, et al.
Publicado: (2017) -
Development of national consensus statements on food labelling interpretation and protein allocation in a low phenylalanine diet for PKU
por: Evans, Sharon, et al.
Publicado: (2019) -
PKU dietary handbook to accompany PKU guidelines
por: MacDonald, A., et al.
Publicado: (2020)